Skip to main content
PLOS One logoLink to PLOS One
. 2021 Feb 16;16(2):e0246970. doi: 10.1371/journal.pone.0246970

Mask usage, social distancing, racial, and gender correlates of COVID-19 vaccine intentions among adults in the US

Carl A Latkin 1,*, Lauren Dayton 1, Grace Yi 1, Brian Colon 2, Xiangrong Kong 3
Editor: Marlene Camacho-Rivera4
PMCID: PMC7886161  PMID: 33592035

Abstract

Vaccine hesitancy could become a significant impediment to addressing the COVID-19 pandemic. The current study examined the prevalence of COVID-19 vaccine hesitancy and factors associated with vaccine intentions. A national panel survey by the National Opinion Research Center (NORC) was designed to be representative of the US household population. Sampled respondents were invited to complete the survey between May 14 and 18, 2020 in English or Spanish. 1,056 respondents completed the survey—942 via the web and 114 via telephone. The dependent variable was assessed by the item “If a vaccine against the coronavirus becomes available, do you plan to get vaccinated, or not?” Approximately half (53.6%) reported intending to be vaccinated, 16.7% did not intend, and 29.7% were unsure. In the adjusted stepwise multinominal logistic regression, Black and Hispanic respondents were significantly less likely to report intending to be vaccinated as were respondents who were females, younger, and those who were more politically conservative. Compared to those who reported positive vaccine intentions, respondents with negative vaccine intentions were significantly less likely to report that they engaged in the COVID-19 prevention behaviors of wearing masks (aOR = 0.53, CI = 0.37–0.76) and social distancing (aOR = 0.22, CI = 0.12–0.42). In a sub-analysis of reasons not to be vaccinated, significant race/ethnic differences were observed. This national survey indicated a modest level of COVID-19 vaccine intention. These data suggest that public health campaigns for vaccine uptake should assess in greater detail the vaccine concerns of Blacks, Hispanics, and women to tailor programs.

Introduction

The death toll of COVID-19 cases and failed pandemic preparedness and response policies in the United States highlight the importance of an effective vaccine to halt the spread of SARS-CoV-2 (COVID-19) [1]. As of mid-December, 2020, the Pfizer- BioNTech vaccine (BNT162b2) had been approved in several countries, the Moderna vaccine (mRNA-1273) has a reported 94.5% efficacy, and the World Health Organization reported that many candidate vaccines were under clinical investigation [2]. Yet, vaccine hesitancy is likely to impair the effectiveness of the rollout of COVID-19 vaccine programs [35]. A May 2020 US national poll suggests that only about half of adults “plan to get vaccinated” if a vaccine against COVID-19 was accessible, and slightly less than a third reported that they were “not sure” if they would get vaccinated [6]. Given the low proportion of Americans who intend to be vaccinated, it is critical to examine factors associated with vaccine hesitancy so that programs can be developed to address these factors and encourage greater levels of COVID-19 vaccine acceptance and use. There are a wealth of studies on vaccine hesitancy, and prior research suggests that attitudes around vaccine hesitancy are difficult to change and are multifaceted, involving beliefs about individual freedoms, trust in government and pharmaceutical companies, and notions of health [712]. Further, it is well recognized that changing attitudes do not necessarily lead to changes in behaviors [1315]. These findings suggest the importance of identifying other strategies to promote vaccine uptake.

Social identity theory argues that people identify with social categories that have normative behaviors. In turn, social identities both define and prescribe individuals’ attitudes and behaviors [16]. This theory suggests that encouraging people to engage in activities that promote an identity, especially a public identity consistent with COVID-19 prevention, could promote vaccine behaviors. Moreover, several theoretical perspectives (e.g., cognitive dissonance) suggest that engaging in behaviors inconsistent with attitudes may lead to attitude change [17]. It is therefore possible that engaging in COVID-19 prevention behaviors may impact COVID-19 vaccine attitudes, even among those with differing political attitudes. Consequently, in the current study, we examined whether the prevention behaviors of mask usage, social distancing, handwashing, and stocking up on food/supplies were associated with COVID-19 vaccine intentions as a positive association could both help guide the development of interventions to improve COVID-19 vaccine uptake as well as predict individuals and potentially geographic regions to target based on current levels of COVID-19 prevention behaviors.

In the current study, we used the National Opinion Research Center (NORC) US national survey data to examine whether the prevention behaviors, independently of political and demographic characteristics, were associated with vaccine intention [18]. These prevention behaviors differ in their private versus public nature, with handwashing and stocking up on food tending to be less public behavior than social distancing and mask wearing. The current analyses allowed us to also examine whether public COVID-19 prevention behaviors may be more strongly linked to vaccine intentions than more private behaviors. Additionally, as racial differences have been found regarding vaccine hesitancy and coverage, which may be partially due to medical mistrust, we also examine racial differences in vaccine hesitancy [1921]. Identification of sub-groups who do not intend to be vaccinated or are hesitant to be vaccinated may help public health officials develop and target strategies for promoting COVID-19 vaccines when safe and effective vaccines become available.

Materials and methods

The present study is based on publicly available survey data from the NORC Center for Public Affairs Research. Data were collected using the AmeriSpeak Omnibus®, which is a monthly survey of a probability-based panel designed to be representative of the US adult population. Randomly selected US households were sampled from the NORC National Sample Frame and then contacted by mail, email, telephone, and field interviewers. The panel is estimated to provide coverage for 97% of the US household population. Interviews for this survey were conducted with adults age 18 and older between May 14 and 18, 2020 residing in the 50 US states or the District of Columbia. This specific study sample was selected from the AmeriSpeak Panel using sampling strata based on age, race/ethnicity, education, and gender. Sampled AmeriSpeak respondents were invited to complete the survey through the member portal or a phone call from an interviewer. The panel reports a recruitment rate of 34%, with approximately 35,000 members. Panel members were randomly drawn from AmeriSpeak, and 1,056 completed the survey—942 via the web and 114 via telephone. Interviews were conducted in English and Spanish. The final stage completion rate was 12.7%, and the weighted household panel response rate was 24.1%. The research protocols were approved by the NORC and Johns Hopkins Bloomberg School of Public Health IRBs. The questionnaire and survey methodology are available at https://apnorc.org/download-data/. The data are available at https://apnorc.org/download-data/covid-19/ and the details of the AmeriSpeak methodology at https://amerispeak.norc.org/Documents/Research/AmeriSpeak%20Technical%20Overview%202019%2002%2018.pdf

Measures

Vaccine intention

The dependent variable on vaccine intentions was assessed by the item, “If a vaccine against the coronavirus becomes available, do you plan to get vaccinated, or not?” The response options were “yes, I will get a coronavirus vaccine,” “no, I will not get a coronavirus vaccine,” and “not sure.”

COVID-19 social identity

Several “yes”/“no” questions assessed for COVID-19 social identity, defined as salient behaviors to address and prevent COVID-19. These questions used the stem, “Which of the following measures, if any, are you taking in response to the outbreak of the new coronavirus?” Answer options included “staying away from large groups,” “wearing a mask when leaving home,” “washing hands more frequently,” “stocking up on cleaning supplies,” and “stocking up on extra food.”

Covariates

To examine the saliency of COVID-19 in their lives, participants were asked, “Have you or has a close friend or relative been diagnosed with the coronavirus by a health care provider, or not (yes/no)?” Worrying about COVID-19 infection was assessed by asking, “How worried are you about you or someone in your family being infected with the coronavirus?” The response categories were on a 7-point scale from “extremely worried” to “not at all worried.” For the analyses, this variable was dichotomized at the median (extremely and very worried vs. somewhat, not too, and not at all worried) to represent higher and lower worry. Political ideology was assessed as a continuous variable from “very liberal” to “very conservative” using a 5-point scale. Respondents were also asked if they have “been unable to pay a credit card bill” because of the COVID-19 outbreak. The question, “How would you describe the community you live in now?” included the response options of “urban,” “rural,” and “suburban.” Age, race/ethnicity, gender, educational achievement, marital status, employment status, and income were also assessed.

Reasons for not getting a COVID-19 vaccine

Individuals who responded, “no, I will not get a coronavirus vaccine,” were also asked, “Which of the following are reasons you would not get a coronavirus vaccine?” Respondents could select multiple reasons and response options included “I am allergic to vaccines,” “I don’t like needles,” “I’m not concerned about getting seriously ill from the coronavirus,” “I won’t have time to get vaccinated,” “I would be concerned about getting infected with the coronavirus from the vaccine,” “I would be concerned about side effects from the vaccine,” “I don’t think vaccines work very well,” and “the coronavirus outbreak is not as serious as some people say it is.”

Analyses

Of the 1,056 respondents, 1,043 provided data on vaccine intentions and hence were included in the analyses. We used bivariate and multivariate multinomial regression models to examine differences among respondents who reported that they did not intend to get the COVID-19 vaccine, when available, compared with those who reported intention to be vaccinated. The multinomial model also assessed the difference between those who were not sure if they would get vaccinated compared to those who intended to get vaccinated. Age and political conservatism were treated as ordinal variables. For regression models, education was dichotomized into high school education versus some college or more. Household income was dichotomized with a median split at $50,000. Multivariable models assessed the relationship between COVID-19 social identity and vaccine intentions (negative vs. positive and unsure vs. positive), adjusting for covariates. Two-sided Fisher’s Exact Test of independence was used to conduct the sub-analysis of racial/ethnic differences in reasons for not planning to be vaccinated among individuals who responded “no” to the vaccine intention question (N = 174).

In the first step of the multivariate multinomial regression models, all demographic variables, regardless of their statistically significant differences in bivariate associations, were included. In the second step, backward stepwise regression was used, with a criterion for retention of p < .10. We also modeled the data with forward stepwise regression and a model with all the variables included and found no appreciable differences in the models. A stepwise approach was used to develop a parsimonious model, as it was anticipated that several of the independent variables would be correlated, p<0.05 was considered statistically significant.

There was minimal missing data (Table 1). For three variables with missing data, linear imputation was used with rounding to the nearest integer to replace missing data for the multivariate regression analysis (missing data: community size, n = 10; worried about COVID-19 affecting family or self, n = 9; political ideology, n = 33). For the two other variables with missing data, the “don’t know” and “missing” responses were recoded as ‘no’ (missing data: unable to pay a credit card bill, n = 4; close friend or relative diagnosed with COVID-19, n = 4). In a sensitivity analysis conducted with models that excluded these cases, the observed magnitudes of association did not change by any appreciable amount.

Table 1. Descriptive statistics for COVID-19 vaccine intentions among NORC national sample (N = 1043).

  Total Yes, I will get the coronavirus vaccine No, I will not get the coronavirus vaccine Not sure
(N = 1043) (n = 559; 53.60%) (n = 174; 16.68%) (n = 310; 29.72%)
n (%) n (%) n (%) n (%)
Age        
18 to 29 71 (6.8) 28 (5.0) 25 (14.4) 18 (5.8)
30 to 39 147 (14.1) 60 (10.7) 28 (16.1) 59 (19.0)
40 to 59 373 (35.8) 166 (29.7) 72 (41.4) 135 (43.6)
60 to 64 118 (11.3) 70 (12.5) 19 (10.9) 29 (9.4)
65 or older 334 (32.0) 235 (42.0) 30 (17.2) 69 (22.3)
Ethnicity        
White 724 (69.4) 437 (78.2) 102 (58.6) 185 (59.7)
Non-Hispanic Black 111 (10.6) 33 (5.9) 35 (20.1) 43 (13.9)
Hispanic 135 (12.9) 52 (9.3) 30 (17.2) 53 (17.1)
Other 73 (7.0) 37 (6.6) 7 (4.0) 29 (9.4)
Gender (Female) 731 (70.1) 355 (63.5) 127 (73.0) 249 (80.3)
Education        
High school and below 203 (19.5) 90 (16.1) 36 (20.7) 77 (24.8)
Some college and above 840 (80.5) 469 (83.9) 138 (79.3) 233 (75.2)
Marital Status (Married) 627 (60.1) 337 (60.3) 97 (55.8) 193 (62.3)
Employment Status        
Employed 591 (56.7) 298 (53.3) 108 (62.1) 185 (59.7)
Income        
Less than $50,000 447 (42.9) 207 (37.0) 96 (55.2) 144 (46.5)
$50,000 or more 596 (57.1) 352 (63.0) 78 (44.8) 166 (53.5)
Community type1        
Urban 297 (28.8) 165 (29.7) 47 (27.3) 85 (27.8)
Suburban 481 (46.6) 270 (48.6) 77 (44.8) 134 (43.8)
Rural 255 (24.7) 120 (21.6) 48 (27.9) 87 (28.4)
Worried about COVID-19 infecting family or self 2        
Extremely Worried 215 (20.8) 129 (23.3) 37 (21.5) 49 (15.9)
Very Worried 225 (21.8) 135 (24.4) 17 (9.9) 73 (23.7)
Somewhat Worried 341 (33.0) 200 (36.1) 38 (22.1) 103 (33.4)
Not too Worried 179 (17.3) 76 (13.7) 42 (24.4) 61 (19.8)
Not at all Worried 74 (7.2) 14 (2.5) 38 (22.1) 22 (7.1)
Self or others diagnosed with COVID-19 (Yes) 192 (18.4) 93 (16.6) 43 (24.7) 56 (18.1)
Behaviors taken to prevent COVID (Yes)        
Staying away from large groups 947 (90.8) 538 (96.2) 130 (74.7) 279 (90.0)
Wearing masks 825 (79.1) 486 (86.9) 98 (56.3) 241 (77.7)
Frequent hand washing 962 (92.2) 532 (95.2) 145 (83.3) 285 (91.9)
Stocking up on supplies 391 (37.5) 213 (38.1) 66 (37.9) 112 (36.1)
Stocking up on food 441 (42.3) 253 (45.3) 71 (40.8) 117 (37.7)
Unable to make credit card payment due to COVID 129 (12.4) 51 (9.1) 34 (19.5) 44 (14.2)
Political orientation3        
Very Liberal 96 (9.5) 69 (12.6) 13 (7.8) 14 (4.7)
Somewhat Liberal 145 (14.4) 100 (18.2) 13 (7.8) 32 (10.8)
Moderate 486 (48.1) 271 (49.5) 63 (37.7) 152 (51.5)
Somewhat Conservative 169 (16.7) 65 (11.9) 41 (24.6) 63 (21.4)
Very Conservative 114 (11.3) 43 (7.8) 37 (22.2) 34 (11.5)

1 These values reflect a response count of N = 1033.

2 These values reflect a response count of N = 1034.

3 These values reflect a response count of N = 1010.

Results

In the study sample, most were in the age groups of 40–59 (35.8%) or 65 or older (32.0%). Most (56.7%) were employed, White (69.4%), and almost half (46.6%) lived in suburban areas (Table 1). In both bivariate multinomial regression models (Table 2), COVID-19 vaccine intention was significantly associated with sociodemographic variables including race (Black, Hispanic, Mixed/other, and White), age group, binary gender, employment status, educational attainment, income level, and political ideology. Participants’ concern that they or someone in their family would become infected was significantly associated with the COVID-19 vaccine intentions in both models. Having already been diagnosed or having a close friend or relative diagnosed with COVID-19 by a healthcare provider was not significantly associated with vaccine intention. Social distancing and mask usage were significantly associated with vaccine intention in the two models, and handwashing was significant in one model (yes vs. no).

Table 2. Unadjusted and adjusted multinomial logistic regression models of COVID-19 vaccine intention.

  Model 1 Model 2
No Not Sure
(Ref: Yes) (Ref: Yes)
  OR aOR OR aOR
(95% CI) (95% CI) (95% CI) (95% CI)
Age group (continuous)* 0.61 0.68 0.71 0.78
(0.53–0.70) (0.57–0.82) (0.63–0.79) (0.67–0.90)
Ethnicity* (Ref: White) REF REF REF REF
Non-Hispanic Black 4.54 6.34 3.08 3.47
(2.70–7.66) (3.46–11.60) (1.90–5.00) (2.04–5.88)
Hispanic 2.47 2.27 2.41 2.1
(1.50–4.07) (1.26–4.08) (1.58–3.66) (1.31–3.39)
Mixed/other 0.81 1.03 1.85 2.13
(0.35–1.87) (0.41–2.55) (1.11–3.10) (1.22–3.71)
Marital Status* (Ref: Married) 0.83 1.02 1.09 1.25
(0.59–1.17) (0.66–1.57) (0.82–1.45) (0.89–1.76)
Gender* (Ref: Female) 1.55 1.74 2.35 2.49
(1.07–2.26) (1.12–2.71) (1.67–3.26) (1.73–3.58)
Employment Status* (Ref: Employed) 0.7 1.01 0.77 0.96
(0.49–0.99) (0.65–1.57) (0.58–1.02) (0.68–1.35)
Income Level* 0.48 0.52 0.68 0.78
(Ref: Less than $50,000) (0.34–0.68) (0.33–0.82) (0.51–0.90) (0.55–1.12)
Education Level* 0.74 1.27 0.58 0.73
(Ref: High school and below) (0.48–1.13) (0.76–2.13) (0.41–0.82) (0.50–1.08)
Level of worry about COVID-19^ (Ref: Not at all worried) 0.5 0.66 0.72 0.69
(0.35–0.72) (0.43–1.03) (0.54–0.95) (0.50–0.95)
Political Orientation^ (Continuous) 1.74 1.82 1.46 1.54
(1.47–2.07) (1.49–2.23) (1.28–1.68) (1.32–1.79)
Staying away from groups^,$ 0.12 0.22 0.35 0.49
(0.07–0.20) (0.12–0.42) (0.20–0.62) (0.26–0.92)
Wearing a mask^ 0.19 0.34 0.53 0.69
(0.13–0.29) (0.21–0.54) (0.37–0.76) (0.46–1.05)
Community Type^ (Ref: Rural) REF REF REF REF
Urban 0.71 --- 0.72 ---
(0.45–1.13) (0.50–1.06)
Suburban 0.71 --- 0.69 ---
(0.47–1.08) (0.49–0.98)
Frequent Hand Washing^, $ 0.25 --- 0.58 ---
(0.15–0.44) (0.33–1.02)
Stocking up on supplies^, $ 0.99 --- 0.92 ---
(0.70–1.41) (0.69–1.23)
Stocking up on food^, $ 0.83 --- 0.73 ---
(0.59–1.18) (0.55–0.97)
Unable to pay Credit Card^, $ 0.41 --- 0.61 ---
(0.26–0.66) (0.40–0.93)
Self or others diagnosed with COVID-19^,$ 0.61 --- 0.91 ---
(0.40–0.92) (0.63–1.30)

Note

*-Variables forced entered into the model

^-Variable backward stepwise entry. Missing aOR values indicate variables that were not included in the final model

$-Dichotomous, “No” was the reference group.

In both of the backward stepwise regression model, several covariates were removed from the final, parsimonious model: community type, frequent hand-washing, stocking up on cleaning supplies or extra food, inability to pay a credit card bill, and COVID-19 diagnosis for self, family, or friends.

As shown in the final model comparing those with negative vaccine intention to positive intention (Table 2), several sociodemographic variables were independently related to the negative intention to obtain a COVID-19 vaccine. Compared to White participants, Black (aOR = 6.34 95% CI = 3.46–11.60) and Hispanic (aOR = 2.27, 95% CI = 1.26–4.08) respondents were significantly more likely to report that they did not intend to obtain a COVID-19 vaccine, if available. Gender was also independently related to vaccine intention, with women being more likely than men to report negative COVID-19 vaccine intention (aOR = 1.74, 95% CI = 1.12–2.71). The increasing age of respondents was also associated with reduced reports of negative vaccine intention (aOR = 0.68, 95% CI = 0.57–0.82). Respondents with an annual income above $50,000 were also less likely to report that they would not obtain a COVID-19 vaccine, if available (aOR = 0.52, 95% CI = 0.33–0.82). Political ideology was independently related to vaccine intention, with increasingly conservative ideology significantly associated with not intending to obtain a potential COVID-19 vaccine (aOR = 1.82, 95% CI = 1.49–2.23).

The item of how worried respondents were that they or a family member would become infected was not significantly associated with intending to obtain a COVID-19 vaccine if available. Interestingly, only the more public preventive behaviors–i.e., social distancing and mask usage–were associated with positive vaccine intention. Those who reported negative vaccine intentions, compared to the positive intention group, had reduced odds of more frequent social distancing and mask usage (aOR = 0.22, 95% CI = 0.12–0.42 and aOR = 0.34, 95% CI = 0.21–0.54, respectively).

The results of the component of the multinomial regression Model 2, which compared those reporting uncertain (“not sure”) intention of obtaining a COVID-19 vaccine to those with positive vaccine intentions (Table 2) identified several sociodemographic factors significantly associated with unsure intention. Compared to White participants, Black participants were more likely to report that they were “not sure” about their intention to obtain a vaccine compared to reporting a positive vaccine intention (aOR = 3.47, 95% CI = 2.04–5.88). Female gender and political conservatism were associated with higher odds of reporting uncertain vaccine intention compared to positive vaccine intention (aOR = 2.49, 95% CI = 1.73–3.58 and aOR = 1.54, 95% CI = 1.32–1.79, respectively). Level of worry about COVID-19 infection was associated with reduced odds of being in the uncertain vaccine intention compared to the positive intention group (aOR = 0.69, 95% CI = 0.50–0.95). Similar to results from multivariate Model 1, more public COVID-19 preventive behaviors were significantly associated with reduced uncertainty about obtaining a vaccine. Staying away from large groups (social distancing) was associated with being less likely to report vaccine uncertainty compared to positive vaccine intentions (aOR = 0.49, 95% CI = 0.26–0.92). Similarly, in bivariate models, mask-wearing was associated with reduced odds of being in the uncertain vaccine intentions group compared to the positive vaccine intentions group (OR = 0.53, 95% CI = 0.37–0.76); however, this finding did not remain significant in the multivariable model.

In a sub-analysis, we analyzed racial/ethnic differences in vaccine hesitancy among individuals who responded “no” to the vaccine intention question (N = 174, Table 3). Fisher’s Exact Tests indicated significant racial/ethnic differences among participants who reported that they would not obtain a vaccine due to a lack of time to get vaccinated (p = 0.013, Fisher’s exact test). Descriptive analyses showed that a proportionately greater number of Black (5.7%) and Hispanic respondents (10.0%) reported a lack of time to get vaccinated as a reason for vaccine refusal compared with 0% of White or “Other race/ethnicity” participants. Fisher’s Exact Test results also revealed racial/ethnic differences in vaccine refusal due to concern about getting infected with COVID-19 from the vaccine (p = 0.004, Fisher’s exact test). Approximately 66% of Black participants cited this concern, followed by 47% Hispanic, 34% White, and 14% “Other race/ethnicity.” Results further indicated that there were significant racial/ethnic differences among respondents who reported that they would not obtain a COVID-19 vaccine if available because the COVID-19 outbreak “is not as serious as some people say it is,” (p = 0.037, Fisher’s exact test). A proportionately greater number of White participants (31.4%) endorsed this reason, as compared with 14.3% of Black and “Other race/ethnicity” participants and 10.0% of Hispanic participants. There were no significant differences in race/ethnicity among respondents who reported vaccine hesitancy/refusal due to allergy to vaccines, dislike of needles, lack of concern about getting seriously ill from COVID-19, concern about vaccine side effects, or belief in vaccine efficacy.

Table 3. Racial/ethnic differences in reported reasons for not intending to obtain a COVID-19 vaccine (N = 174).

Which of the following are reasons you would not get a coronavirus vaccine? African-American Hispanic Other White, non-Hispanic Fisher’s Exact Test (two-sided)
  (n = 35, 20.1%) (n = 30; 17.2%) (n = 7; 4.10%) (n = 102; 58.60%) p-value
I am allergic to vaccines 3 (8.6) 0 (0.0) 0 (0.0) 7 (6.9) 0.454
I don’t like needles 6 (17.1) 6 (20.0) 0 (0.0) 9 (8.8) 0.218
I’m not concerned about getting seriously ill from the coronavirus 10 (28.6) 4 (13.3) 2 (28.6) 37 (36.3) 0.099
I won’t have time to get vaccinated 2 (5.7) 3 (10.0) 0 (0.0) 0 (0.0) 0.013
I would be concerned about getting infected with the coronavirus from the vaccine 23 (65.7) 14 (46.7) 1 (14.3) 35 (34.3) 0.004
I would be concerned about side effects from the vaccine 26 (74.3) 19 (63.3) 6 (85.7) 73 (71.6) 0.661
I don’t think vaccines work very well 13 (37.1) 6 (20.0) 3 (42.9) 33 (32.4) 0.404
The coronavirus outbreak is not as serious as some people say it is 5 (14.3) 3 (10.0) 1 (14.3) 32 (31.4) 0.037

Discussion

From this well characterized US national representative study, we found that the three groups of vaccine intention (yes/no/not sure) significantly differed based on background factors and COVID-19 social identity. Not surprisingly, those with positive COVID-19 vaccine intention were more different from those with negative vaccine intention than those with unsure intention. Black and Hispanic respondents were significantly less likely to report intending to obtain a vaccine than White respondents. Surprisingly, women were less likely to report intending to be vaccinated, which differs from results indicated by prior studies [22]. These results suggest that a COVID-19 social identity, as assessed through engagement in COVID-19 prevention behaviors, is associated with vaccine intention. With regard to COVID-19 preventive measures, the more public behaviors of mask usage and social distancing were strongly associated with vaccine intentions, whereas handwashing and stocking up on food/supplies were not associated in the multivariate models. This finding is consistent with social identity theory, as handwashing and stocking up on supplies are more private preventive behaviors and thus may differ from the more public COVID-19 prevention behaviors. Additionally, handwashing and stocking of food/supplies may not be strong indicators of COVID-19-prevention identity as they are not behaviors specific to COVID-19 prevention. We do not know if there is a causal association between the COVID-19 prevention identity and vaccine intention variables, and hence this warrants a longitudinal assessment. Political conservativism was found to be associated with not intending to be vaccinated. Prior research on vaccine hesitancy has found mixed results on the role of political ideology on vaccine hesitancy [23, 24]. We do not know if the current politicization and polarization of COVID-19 have had a unique impact on COVID-19 vaccine hesitancy.

This study is subject to several limitations. It is unknown whether hesitancy predicts actual behaviors or if COVID-19 vaccine hesitancy will change when a vaccine is developed, either based on the vaccine’s effectiveness/side-effects, or as a result of the future political climate. The study is also limited by the cross-sectional design as well as its reliance on self-reported data. Consequently, we do not know if a heightened identity of COVID-19 prevention or engaging in COVID-19 prevention behaviors will lead to greater vaccine acceptance. Moreover, since it was designed to be nationally representative, high risk and some minority subgroups had small cell sizes, limiting analyses and inferences. Another limitation is that the study focused only on individual-level factors rather than structural barriers to vaccine uptake. It may be more fruitful to also conceptualize vaccine uptake as a community and systems-level variable and provide community-level incentives for high vaccination rates. In addition, there were no criteria provided to respondents in selection of community type (rural, suburban, urban). Participants’ self-identification of community type may vary in accuracy and limit the interpretability of particular study findings relevant to community size. Furthermore, study findings may be less representative of certain populations whom, for example, may have high levels of distrust for the media and polls and hence did not respond. Moreover, social desirability bias is not likely to be randomly distributed and may have impacted the study findings as well as the mode of survey administration.

The lower likelihood of Black and Hispanic participants to report intending to obtain a COVID-19 vaccine when available is disconcerting, especially given the COVID-19 mortality disparities with much higher rates among Black and Hispanic patients in the US [25, 26]. A sub-analysis among respondents who did not plan to obtain a COVID-19 vaccine indicated that Blacks, compared to Whites, were almost twice as likely to report concerns about becoming infected from the vaccine. In contrast, Whites, compared to other racial/ethnic groups, were more than twice as likely to report that one of the reasons for not intending to get a vaccine was that “the coronavirus outbreak is not as serious as some people say it is.” These findings are from a subsample and highlight the importance of studies examining racial/ethnic differences in vaccine intentions.

These data suggest that public health campaigns for vaccine uptake should assess in greater detail the vaccine concerns of Black and Hispanic US residents to tailor vaccine uptake programs. Future research should longitudinally examine whether social distancing and mask usage policies enacted by states, counties, and cities have an impact on vaccine hesitancy as well as monitor vaccine hesitancy in real-time to help predict levels of vaccine uptake and inform future public health campaigns aiming to improve vaccination rates. A high degree of hope has been placed on a vaccine to eradicate SARS-CoV-2. However, unless there are active and targeted campaigns to foster vaccine uptake and access, the public health impact of an effective vaccine is uncertain.

Data Availability

All raw data files are available from the database https://www.norc.org/Research/Projects/Pages/covid-impact-survey.aspx.

Funding Statement

This study received support from the following sources: National Institute on Drug Abuse (US), grant R01 DA040488, awarded to CAL; Johns Hopkins Alliance for a Healthier World, awarded to CAL.

References

  • 1.Chaudhry R, Dranitsaris G, Mubashir T, Bartoszko J, Riazi S. A country level analysis measuring the impact of government actions, country preparedness and socioeconomic factors on COVID-19 mortality and related health outcomes. E Clinical Medicine. 2020:100464 10.1016/j.eclinm.2020.100464 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.World Health Organization. Draft landscape of COVID-19 candidate vaccines. https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines. Updated August, 2020.
  • 3.Dror AA, Eisenbach N, Taiber S, et al. Vaccine hesitancy: The next challenge in the fight against COVID-19. Eur J Epidemiol. 2020:1–5. 10.1007/s10654-020-00616-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Megget K. Even covid-19 can’t kill the anti-vaccination movement. BMJ. 2020;369:m2184 10.1136/bmj.m2184 [DOI] [PubMed] [Google Scholar]
  • 5.COCONEL Group. A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation. The Lancet. Infectious Diseases. 10.1016/S1473-3099(20)30426-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.The Associated Press-NORC Center for Public Affairs Research. The may 2020 AP-NORC center poll. https://apnorc.org/wp-content/uploads/2020/06/may-topline.pdf. Updated 2020.
  • 7.Hornsey MJ, Harris EA, Fielding KS. The psychological roots of anti-vaccination attitudes: A 24-nation investigation. Health Psychology. 2018;37(4):307 10.1037/hea0000586 [DOI] [PubMed] [Google Scholar]
  • 8.Opel DJ, Henrikson N, Lepere K, et al. Previsit screening for parental vaccine hesitancy: A cluster randomized trial. Pediatrics. 2019;144(5) 10.1542/peds.2019-0802 Epub 2019 Oct 9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Dube E, Vivion M, MacDonald NE. Vaccine hesitancy, vaccine refusal and the anti-vaccine movement: Influence, impact and implications. Expert review of vaccines. 2015;14(1):99–117. 10.1586/14760584.2015.964212 [DOI] [PubMed] [Google Scholar]
  • 10.Mills EJ, Montori VM, Ross CP, Shea B, Wilson K, Guyatt GH. Systematically reviewing qualitative studies complements survey design: An exploratory study of barriers to paediatric immunisations. J Clin Epidemiol. 2005;58(11):1101–1108. 10.1016/j.jclinepi.2005.01.014 [DOI] [PubMed] [Google Scholar]
  • 11.Larson HJ, Jarrett C, Eckersberger E, Smith DM, Paterson P. Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: A systematic review of published literature, 2007–2012. Vaccine. 2014;32(19):2150–2159. 10.1016/j.vaccine.2014.01.081 [DOI] [PubMed] [Google Scholar]
  • 12.Amin AB, Bednarczyk RA, Ray CE, et al. Association of moral values with vaccine hesitancy. Nature Human Behaviour. 2017;1(12):873–880. 10.1038/s41562-017-0256-5 [DOI] [PubMed] [Google Scholar]
  • 13.Sheeran P, Maki A, Montanaro E, et al. The impact of changing attitudes, norms, and self-efficacy on health-related intentions and behavior: A meta-analysis. Health Psychology. 2016;35(11):1178 10.1037/hea0000387 [DOI] [PubMed] [Google Scholar]
  • 14.Giese H, Neth H, Moussaïd M, Betsch C, Gaissmaier W. The echo in flu-vaccination echo chambers: Selective attention trumps social influence. Vaccine. 2020;38(8):2070–2076. 10.1016/j.vaccine.2019.11.038 [DOI] [PubMed] [Google Scholar]
  • 15.Kraus SJ. Attitudes and the prediction of behavior: A meta-analysis of the empirical literature. Person Soc Psychol Bull. 1995;21(1):58–75. [Google Scholar]
  • 16.Hogg MA, Terry DJ, White KM. A tale of two theories: A critical comparison of identity theory with social identity theory. Soc Psychol Q. 1995:255–269. [Google Scholar]
  • 17.Martinie M, Almecija Y, Ros C, Gil S. Incidental mood state before dissonance induction affects attitude change. Plos One. 2017;12(7):e0180531 10.1371/journal.pone.0180531 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.The Associated Press-NORC Center for Public Affairs Research. Expectations for a COVID-19 vaccine: The may 2020 AP-NORC center poll. https://apnorc.org/projects/expectations-for-a-covid-19-vaccine/. Updated 2020.
  • 19.Centers for Disease Control and Prevention. Flu vaccination coverage, United States, 2018–19 influenza season. https://www.cdc.gov/flu/fluvaxview/coverage-1819estimates.htm. Updated 2019.
  • 20.Quinn SC, Jamison AM, Freimuth VS, An J, Hancock GR. Determinants of influenza vaccination among high-risk Black and white adults. Vaccine. 2017;35(51):7154–7159. 10.1016/j.vaccine.2017.10.083 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Quinn SC, Jamison A, Freimuth VS, An J, Hancock GR, Musa D. Exploring racial influences on flu vaccine attitudes and behavior: Results of a national survey of white and African American adults. Vaccine. 2017;35(8):1167–1174. 10.1016/j.vaccine.2016.12.046 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Cacciatore MA, Nowak GJ, Evans NJ. It’s complicated: The 2014–2015 US measles outbreak and parents’ vaccination beliefs, confidence, and intentions. Risk Analysis. 2018;38(10):2178–2192. 10.1111/risa.13120 [DOI] [PubMed] [Google Scholar]
  • 23.Buckman C, Liu IC, Cortright L, Tumin D, Syed S. The influence of local political trends on childhood vaccine completion in North Carolina. Soc Sci Med. 2020:113187 10.1016/j.socscimed.2020.113187 [DOI] [PubMed] [Google Scholar]
  • 24.Żuk P, Żuk P. Right-wing populism in Poland and anti-vaccine myths on YouTube: Political and cultural threats to public health. Global Public Health. 2020;15(6):790–804. 10.1080/17441692.2020.1718733 [DOI] [PubMed] [Google Scholar]
  • 25.Bhala N, Curry G, Martineau AR, Agyemang C, Bhopal R. Sharpening the global focus on ethnicity and race in the time of COVID-19. The Lancet. 2020. May 30;395(10238):1673–6. 10.1016/S0140-6736(20)31102-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.National Center for Health Statistics. Provisional death counts for coronavirus disease 2019 (COVID-19). Centers for Disease Control and Prevention. 2020 Jun 24.

Decision Letter 0

Marlene Camacho-Rivera

8 Dec 2020

PONE-D-20-33455

Mask usage, social distancing, racial, and gender correlates of COVID-19 vaccine intentions among adults in the US.

PLOS ONE

Dear Dr. Latkin,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript within 60 days of receipt of this decision email. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Marlene Camacho-Rivera, ScD, MPH

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please include additional information regarding the survey or questionnaire used in the study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed a questionnaire as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information, or include a citation if it has been published previously.

3. In the Methods, please discuss whether and how the questionnaire was validated and/or pre-tested.

4. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ

5. We note you have included a table to which you do not refer in the text of your manuscript. Please ensure that you refer to Table 3 in your text; if accepted, production will need this reference to link the reader to the Table.

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Very interesting and informative study that could help guide messages to improve vaccine adherence.

A couple of points to address:

Intro

- The first sentence of the last paragraph (In the current study...) - appears to be an incomplete sentences

Methods

- What were the criteria (or examples given to respondents, if any) for urban, suburban or rural communities respondents live in?

Results

- There is a discrepancy in how the the variables are treated in Table 1 and Table 2. In Table 1, the variable age for example, is treated as categorical but linear in Table 2. The same for Level of Worry. If they are intended to treated as categorical in table 2, please adjust tables and ensure all variables have identified references with justifications.

Discussion

- If there were no criteria for respondents selection of community type, please address in limitations

- Given abundance of misinformation found on the internet, would recommend discussing the proportion of web-based respondents as a potential limitation

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Feb 16;16(2):e0246970. doi: 10.1371/journal.pone.0246970.r002

Author response to Decision Letter 0


10 Dec 2020

Dear Editors,

Below please find in bold the responses to the editors’ and reviewers’ questions.

Journal Requirements:

When submitting your revision, we need you to address these additional requirements

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

We have now used the PLOS ONE's style requirements

2. Please include additional information regarding the survey or questionnaire used in the study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed a questionnaire as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information, or include a citation if it has been published previously.

We have provided the web link to the survey and data.

3. In the Methods, please discuss whether and how the questionnaire was validated and/or pre-tested.

We now include a web link to the larger study's methods and methodologies that provide copious details on the study methods. The survey items on vaccine intentions were based on items on seasonal influenzas vaccine intentions from CDC.

4. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to 'Update my Information' (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ

We include the ORCID iD for the corresponding author (0000-0002-7931-2116)

5. We note you have included a table to which you do not refer in the text of your manuscript. Please ensure that you refer to Table 3 in your text; if accepted, production will need this reference to link the reader to the Table.

We have now included the reference for Table 3 in the text.

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

________________________________________

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

________________________________________

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

________________________________________

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

________________________________________

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Very interesting and informative study that could help guide messages to improve vaccine adherence.

A couple of points to address:

Intro

- The first sentence of the last paragraph (In the current study...) - appears to be an incomplete sentences

We have edited this sentence for clarity.

Methods

- What were the criteria (or examples given to respondents, if any) for urban, suburban or rural communities respondents live in?

Community size was assessed only by the question: “How would you describe the community you live in now?” Respondents were provided the options of “urban,” “rural,” and “suburban” and self-reported their community size. Of the sample, 24.8% were rural, 28.5% urban, and 6.5% suburban, which suggests a geographically diverse sample. We have referred the readers to 2 detailed appendices on the recruitment and enrollment, which also provides the descriptive statistics, on all the variables, as well as included additional text about the criteria.

The only enrollment criteria included adults age 18 and older who were residing in the 50 states and the District of Columbia at the time of survey. As the goal of the panel was to be representative of the US adult population, albeit with weighting, it was open to all adults. In addition to developing national representative sample, the panel was designed to be representative to eight US regions.

Results

- There is a discrepancy in how the the variables are treated in Table 1 and Table 2. In Table 1, the variable age for example, is treated as categorical but linear in Table 2. The same for Level of Worry. If they are intended to treated as categorical in table 2, please adjust tables and ensure all variables have identified references with justifications.

Tables 1 and 2 now consistently reflect the categorical ‘Level of Worry’ variable and Table 2 provides the appropriate reference category. We also clarified that we used the same variables in the two tables. In addition, we have now identified the reference categories for all the categorical variables in Table 2 to clarify that they were treated the same in both tables

Discussion

- If there were no criteria for respondents selection of community type, please address in limitations

We now include in the limitation section that there were no criteria for respondents’ self-report of community type. The following information was added to the Limitations section:

“In addition, there were no criteria provided to respondents in selection of community type (rural, suburban, urban). Participants’ self-identification of community type may be the sample may be inaccurate and limit the interpretability of particular study findings relevant to community size.”

We also include the limitation that the sample is less representative of certain populations whom, for example, may have high levels distrust for the media and polls and hence did not respond. Moreover, social desirability bias is not likely to be randomly distributed and may have had an impact on the study findings.

- Given abundance of misinformation found on the internet, would recommend discussing the proportion of web-based respondents as a potential limitation

We now state that we also do not know how the mode of administration may be linked to response biases in this survey. The following has been added to the “Limitations” section:

“Furthermore, study findings may be less representative of certain populations whom, for example, may have high levels of distrust for the media and polls and hence did not respond. Moreover, social desirability bias is not likely to be randomly distributed and may have impacted the study findings as well as the mode of survey administration.”

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Marlene Camacho-Rivera

29 Jan 2021

Mask usage, social distancing, racial, and gender correlates of COVID-19 vaccine intentions among adults in the US.

PONE-D-20-33455R1

Dear Dr. Latkin,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Marlene Camacho-Rivera, ScD, MPH

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Thank you for your prompt resubmission. All comments have been throroughly addressed and the revised manuscript is suitable for publication. 

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: (No Response)

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: (No Response)

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: (No Response)

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: (No Response)

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Acceptance letter

Marlene Camacho-Rivera

5 Feb 2021

PONE-D-20-33455R1

Mask usage, social distancing, racial, and gender correlates of COVID-19 vaccine intentions among adults in the US. 

Dear Dr. Latkin:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Marlene Camacho-Rivera

Academic Editor

PLOS ONE


Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES